- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/635 - Hormone parathyroïdienne, c.-à-d. parathormonePeptides dérivés de l'hormone parathyroïdienne
Détention brevets de la classe C07K 14/635
Brevets de cette classe: 208
Historique des publications depuis 10 ans
|
13
|
13
|
7
|
22
|
19
|
16
|
20
|
7
|
10
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1158 |
28 |
| The General Hospital Corporation | 4797 |
13 |
| Board of Trustees of the University of Arkansas | 824 |
10 |
| National University Corporation Kagawa University | 210 |
8 |
| Ochsner Clinic Foundation | 26 |
7 |
| Radius Health, Inc. | 95 |
7 |
| Hybio Pharmaceutical Co., Ltd. | 121 |
4 |
| Wisconsin Alumni Research Foundation | 3891 |
3 |
| Takeda Pharmaceutical Company Limited | 2717 |
3 |
| Purdue Research Foundation | 3726 |
3 |
| ALZA Corporation | 87 |
3 |
| Asahi Kasei Pharma Corporation | 124 |
3 |
| Cadila Healthcare Limited | 313 |
3 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 28 |
3 |
| Indiana University Research and Technology Corporation | 797 |
3 |
| The Kitasato Institute | 160 |
3 |
| University of Massachusetts | 2257 |
3 |
| The Johns Hopkins University | 5751 |
2 |
| Alkem Laboratories Limited | 66 |
2 |
| AmideBio, LLC | 15 |
2 |
| Autres propriétaires | 95 |